APVO

APVO

USD

Aptevo Therapeutics Inc. Common Stock

$1.470+0.060 (4.255%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$1.410

High

$1.500

Low

$1.390

Volume

1.20M

Company Fundamentals

Market Cap

20.3M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

5.70M

Exchange

NCM

Currency

USD

52-Week Range

Low $1.32Current $1.470High $298

Related News

AccessWire

Aptevo Debuts First Trispecific Antibody Candidate, APVO451, with Preclinical Data Demonstrating Immune Activation in Hard-to-Treat Solid Tumors

First data on Aptevo's new molecule presented at the Society for Immunotherapy of Cancer Annual Meeting SEATTLE, WASHINGTON / ACCESS Newswire / November 10, 2025 / Aptevo Therapeutics ("Aptevo" or the

View more
Aptevo Debuts First Trispecific Antibody Candidate, APVO451, with Preclinical Data Demonstrating Immune Activation in Hard-to-Treat Solid Tumors